Allogene Therapeutics: Q3 Earnings Snapshot
By AP News
Published - Nov 07, 2024, 04:12 PM ET
Last Updated - Dec 16, 2024, 05:35 PM EST
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $66.3 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 32 cents. Losses, adjusted for asset impairment costs, were 27 cents per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
In the final minutes of trading on Thursday, the company's shares hit $3.20. A year ago, they were trading at $3.28.